Return to Publications
December 2017
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.
Prostate cancer ribbon

Rutgers Cancer Institute Physician-Scientist Awarded U.S. Department of Defense Grant for Prostate Cancer Research

Isaac Yi Kim, MD, PhD, MBA, urologic oncology section chief at Rutgers Cancer Institute of New Jersey and associate professor of surgery at Rutgers Robert Wood Johnson Medical School, has been awarded a $954,000 Prostate Cancer Research Program Idea Development Award for Established Investigators (W81XWH-17-1-0359). The funding from the United States Department of Defense supports Dr. Kim's research on how neuroendocrine markers impact a common treatment for a type of prostate cancer that does not respond to testosterone-lowering therapies.

Holidays

Avoid the Holiday Food Trap

Typically around the holidays, healthy eating habits established over the year go by the wayside. Rutgers Cancer Institute of New Jersey registered dietitian Lori Magoulas, PhD, RD, shares a few tips to keep your waistline and overall health in check this holiday season including making small substitutions, going with half portions or not leaving the house hungry.

genetics

Shedding Light on New Therapeutic Strategies for Breast Cancer

Rutgers Cancer Institute of New Jersey research further elucidates a tumor suppression mechanism behind the human Parkin gene - which could help inform treatment decisions for breast cancer patients who have a Parkin mutation or loss of Parkin expression. Investigators from the Cancer Institute's Genomic Instability and Cancer Genetics ProgramCancer Metabolism and Growth Program, and Clinical Investigations and Precision Therapeutics Research Program, collaborated on the project.

screening

Teaming Up to Fight Colorectal Cancer

Rutgers Cancer Institute of New Jersey, Rutgers Health, and University Hospital in Newark have announced their commitment to increase colorectal cancer screening across New Jersey by joining a national effort with the American Cancer Society in the fight against this disease. The national percentage of adults 50 and older that are up to date with recommended colorectal cancer screening has increased from 56 percent in 2002 to 65 percent in 2010. By focusing on target audiences, Rutgers and University Hospital aim to achieve 80 percent screened for colorectal cancer during 2018.

screening

See, Test & Treat

A community health outreach and education event called 'See, Test & Treat' at Rutgers Cancer Institute of New Jersey at University Hospital resulted in 63 participants being screened for cancer. Damali M. Campbell-Oparaji, MD, Rutgers New Jersey Medical School assistant professor of obstetrics, gynecology and women's health along with colleagues Debra S. Heller, MD, and Basil Hubbi, MD'03 - with the encouragement of Mark H. Einstein, MD, chair of obstetrics, gynecology and women's health - teamed up to bring the benefits of diagnostic medicine to women of Newark and surrounding communities in the form of free screenings for cervical and breast cancers.